Journal article
High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination
Abstract
COVID-19 exposure in Central Asia appears underestimated and SARS-CoV-2 seroprevalence data are urgently needed to inform ongoing vaccination efforts and other strategies to mitigate the regional pandemic. Here, in a pilot serologic study we assessed the prevalence of SARS-CoV-2 antibody-mediated immunity in a multi-ethnic cohort of public university employees in Karaganda, Kazakhstan. Asymptomatic subjects (n = 100) were recruited prior to …
Authors
Kadyrova I; Yegorov S; Negmetzhanov B; Kolesnikova Y; Kolesnichenko S; Korshukov I; Akhmaltdinova L; Vazenmiller D; Stupina Y; Kabildina N
Journal
PLOS ONE, Vol. 17, No. 7,
Publisher
Public Library of Science (PLoS)
DOI
10.1371/journal.pone.0272008
ISSN
1932-6203